HK Stock MarketDetailed Quotes

TIGERMED (03347)

Watchlist

39.100
-0.800-2.01%

Not Open Jul 7 16:07 CST

33.67BMarket Cap92.65P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TIGERMED (03347) Income Statement

All

YOY

Hide blank lines

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

Turnover

-5.79%1.56B

-10.58%6.6B

-10.32%5.07B

-9.50%3.36B

-8.00%1.66B

4.21%7.38B

4.52%5.65B

3.25%3.71B

-0.73%1.8B

35.91%7.09B

Operating income

-5.79%1.56B

-10.58%6.6B

-10.32%5.07B

-9.50%3.36B

-8.00%1.66B

4.21%7.38B

4.52%5.65B

3.25%3.71B

-0.73%1.8B

35.91%7.09B

Cost of sales

----

-45.01%-4.3B

Operating expenses

-6.04%-1.09B

3.85%-4.36B

8.12%-3.1B

9.17%-2.03B

5.23%-1.03B

-5.48%-4.54B

-4.12%-3.37B

-2.48%-2.23B

2.06%-1.09B

-45.01%-4.3B

Gross profit

-25.21%469.76M

-21.29%2.24B

-13.57%1.97B

-10.00%1.33B

-12.21%628.12M

2.26%2.85B

5.12%2.28B

4.42%1.48B

1.37%715.52M

23.90%2.79B

Selling expenses

-4.83%-48.7M

-10.83%-207.61M

-9.22%-144.94M

-13.91%-101.38M

-3.43%-46.45M

-24.97%-187.31M

-22.94%-132.7M

-11.19%-89M

-16.61%-44.91M

-15.84%-149.89M

Administrative expenses

-1.93%-180.49M

-13.33%-736.84M

-5.85%-558.43M

-8.70%-376.62M

-3.60%-177.07M

-1.07%-650.2M

-14.39%-527.54M

-7.81%-346.47M

-7.54%-170.92M

-15.95%-643.32M

Research and development expenses

7.56%-59.08M

8.86%-238.39M

11.90%-172.1M

2.65%-124.69M

0.95%-63.91M

-11.48%-261.56M

-14.20%-195.34M

-15.89%-128.08M

-13.22%-64.52M

-10.76%-234.62M

Profit from asset sales

-49.92%577.12K

1,994.43%3.56M

5,815.94%2.67M

25,346.07%1.49M

32,651.46%1.15M

---188.09K

282.55%45.22K

---5.9K

41.47%-3.54K

----

Revaluation surplus

-275.58%-22.39M

-242.21%-501.69M

-104.84%-34.41M

-118.58%-98.4M

-92.77%12.75M

--352.77M

76.46%710.39M

--529.76M

40.98%176.41M

----

-Changes in the fair value of other assets

-275.58%-22.39M

-242.21%-501.69M

-104.84%-34.41M

-118.58%-98.4M

-92.77%12.75M

--352.77M

76.46%710.39M

--529.76M

40.98%176.41M

----

Impairment and provision

20.54%-14.62M

50.04%-34.02M

-21.51%-55.1M

-21.18%-36.08M

11.22%-18.4M

-177.10%-68.1M

-0.74%-45.34M

-4.81%-29.78M

-76.90%-20.73M

-0.61%-24.58M

-Other impairment is provision

20.54%-14.62M

50.04%-34.02M

-21.51%-55.1M

-21.18%-36.08M

11.22%-18.4M

-177.10%-68.1M

-0.74%-45.34M

-4.81%-29.78M

-76.90%-20.73M

-0.61%-24.58M

Special items of operating profit

224.47%38.22M

-45.38%203.49M

-5.47%130.76M

-18.28%88.09M

-61.93%11.78M

-58.85%372.54M

25.78%138.34M

-81.95%107.8M

-50.70%30.94M

-61.84%905.28M

Operating profit

-48.20%176.25M

-70.47%702.49M

-49.39%1.12B

-55.58%670.96M

-44.66%340.28M

-9.84%2.38B

17.21%2.21B

2.38%1.51B

-1.46%614.94M

-28.70%2.64B

Financing cost

-244.84%-31.75M

-135.14%-38.07M

-129.66%-31.37M

-81.71%16.11M

37.34%21.92M

230.23%108.32M

-11.06%105.76M

383.86%88.09M

-47.37%15.96M

-233.92%-83.18M

Share of profits of associates

----

177.13%39.76M

Adjustment items of earning before tax

-623.31%-879.04K

-97.33%42.5K

-24.63%2.07M

452.48%3.02M

2.21%167.98K

--1.59M

-45.03%2.75M

--547.3K

-89.86%164.35K

----

Earning before tax

-60.36%143.63M

-73.30%664.46M

-53.03%1.09B

-56.85%690.09M

-42.58%362.36M

-4.10%2.49B

15.38%2.31B

8.06%1.6B

-3.80%631.06M

-29.67%2.59B

Tax

32.43%-33.64M

36.02%-216.63M

35.83%-183.93M

30.64%-132.51M

20.63%-49.79M

-7.96%-338.61M

-22.61%-286.62M

-17.76%-191.06M

23.52%-62.74M

-7.10%-313.65M

After-tax profit from continuing operations

-64.81%109.98M

-79.17%447.83M

-55.46%903.14M

-60.40%557.58M

-45.00%312.57M

-5.76%2.15B

14.42%2.03B

6.87%1.41B

-0.98%568.33M

-32.84%2.28B

Earning after tax

-64.81%109.98M

-79.17%447.83M

-55.46%903.14M

-60.40%557.58M

-45.00%312.57M

-5.76%2.15B

14.42%2.03B

6.87%1.41B

-0.98%568.33M

-32.84%2.28B

Minority profit

-171.60%-55.49M

-65.87%42.69M

-39.49%89.71M

227.70%64.73M

59,975.46%77.5M

-52.83%125.08M

-11.54%148.24M

-84.28%19.75M

-100.23%-129.43K

-48.76%265.17M

Profit attributable to shareholders

-29.61%165.47M

-79.99%405.14M

-56.72%813.43M

-64.50%492.85M

-58.65%235.07M

0.43%2.02B

17.13%1.88B

16.47%1.39B

9.65%568.46M

-29.98%2.02B

Basic earnings per share

-29.63%0.19

-79.91%0.47

-56.68%0.94

-64.60%0.57

-59.09%0.27

0.43%2.34

16.67%2.17

16.67%1.61

10.00%0.66

-29.82%2.33

Diluted earnings per share

-29.63%0.19

-79.91%0.47

-56.68%0.94

-64.60%0.57

-59.09%0.27

0.43%2.34

16.67%2.17

16.67%1.61

10.00%0.66

-29.61%2.33

Currency Unit

CNY

Accounting Standards

CAS (2007)

IAS

Audit Opinions

Unqualified Opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited

	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022
Turnover	-5.79%1.56B	-10.58%6.6B	-10.32%5.07B	-9.50%3.36B	-8.00%1.66B	4.21%7.38B	4.52%5.65B	3.25%3.71B	-0.73%1.8B	35.91%7.09B
Operating income	-5.79%1.56B	-10.58%6.6B	-10.32%5.07B	-9.50%3.36B	-8.00%1.66B	4.21%7.38B	4.52%5.65B	3.25%3.71B	-0.73%1.8B	35.91%7.09B
Cost of sales	----	----	----	----	----	----	----	----	----	-45.01%-4.3B
Operating expenses	-6.04%-1.09B	3.85%-4.36B	8.12%-3.1B	9.17%-2.03B	5.23%-1.03B	-5.48%-4.54B	-4.12%-3.37B	-2.48%-2.23B	2.06%-1.09B	-45.01%-4.3B
Gross profit	-25.21%469.76M	-21.29%2.24B	-13.57%1.97B	-10.00%1.33B	-12.21%628.12M	2.26%2.85B	5.12%2.28B	4.42%1.48B	1.37%715.52M	23.90%2.79B
Selling expenses	-4.83%-48.7M	-10.83%-207.61M	-9.22%-144.94M	-13.91%-101.38M	-3.43%-46.45M	-24.97%-187.31M	-22.94%-132.7M	-11.19%-89M	-16.61%-44.91M	-15.84%-149.89M
Administrative expenses	-1.93%-180.49M	-13.33%-736.84M	-5.85%-558.43M	-8.70%-376.62M	-3.60%-177.07M	-1.07%-650.2M	-14.39%-527.54M	-7.81%-346.47M	-7.54%-170.92M	-15.95%-643.32M
Research and development expenses	7.56%-59.08M	8.86%-238.39M	11.90%-172.1M	2.65%-124.69M	0.95%-63.91M	-11.48%-261.56M	-14.20%-195.34M	-15.89%-128.08M	-13.22%-64.52M	-10.76%-234.62M
Profit from asset sales	-49.92%577.12K	1,994.43%3.56M	5,815.94%2.67M	25,346.07%1.49M	32,651.46%1.15M	---188.09K	282.55%45.22K	---5.9K	41.47%-3.54K	----
Revaluation surplus	-275.58%-22.39M	-242.21%-501.69M	-104.84%-34.41M	-118.58%-98.4M	-92.77%12.75M	--352.77M	76.46%710.39M	--529.76M	40.98%176.41M	----
-Changes in the fair value of other assets	-275.58%-22.39M	-242.21%-501.69M	-104.84%-34.41M	-118.58%-98.4M	-92.77%12.75M	--352.77M	76.46%710.39M	--529.76M	40.98%176.41M	----
Impairment and provision	20.54%-14.62M	50.04%-34.02M	-21.51%-55.1M	-21.18%-36.08M	11.22%-18.4M	-177.10%-68.1M	-0.74%-45.34M	-4.81%-29.78M	-76.90%-20.73M	-0.61%-24.58M
-Other impairment is provision	20.54%-14.62M	50.04%-34.02M	-21.51%-55.1M	-21.18%-36.08M	11.22%-18.4M	-177.10%-68.1M	-0.74%-45.34M	-4.81%-29.78M	-76.90%-20.73M	-0.61%-24.58M
Special items of operating profit	224.47%38.22M	-45.38%203.49M	-5.47%130.76M	-18.28%88.09M	-61.93%11.78M	-58.85%372.54M	25.78%138.34M	-81.95%107.8M	-50.70%30.94M	-61.84%905.28M
Operating profit	-48.20%176.25M	-70.47%702.49M	-49.39%1.12B	-55.58%670.96M	-44.66%340.28M	-9.84%2.38B	17.21%2.21B	2.38%1.51B	-1.46%614.94M	-28.70%2.64B
Financing cost	-244.84%-31.75M	-135.14%-38.07M	-129.66%-31.37M	-81.71%16.11M	37.34%21.92M	230.23%108.32M	-11.06%105.76M	383.86%88.09M	-47.37%15.96M	-233.92%-83.18M
Share of profits of associates	----	----	----	----	----	----	----	----	----	177.13%39.76M
Adjustment items of earning before tax	-623.31%-879.04K	-97.33%42.5K	-24.63%2.07M	452.48%3.02M	2.21%167.98K	--1.59M	-45.03%2.75M	--547.3K	-89.86%164.35K	----
Earning before tax	-60.36%143.63M	-73.30%664.46M	-53.03%1.09B	-56.85%690.09M	-42.58%362.36M	-4.10%2.49B	15.38%2.31B	8.06%1.6B	-3.80%631.06M	-29.67%2.59B
Tax	32.43%-33.64M	36.02%-216.63M	35.83%-183.93M	30.64%-132.51M	20.63%-49.79M	-7.96%-338.61M	-22.61%-286.62M	-17.76%-191.06M	23.52%-62.74M	-7.10%-313.65M
After-tax profit from continuing operations	-64.81%109.98M	-79.17%447.83M	-55.46%903.14M	-60.40%557.58M	-45.00%312.57M	-5.76%2.15B	14.42%2.03B	6.87%1.41B	-0.98%568.33M	-32.84%2.28B
Earning after tax	-64.81%109.98M	-79.17%447.83M	-55.46%903.14M	-60.40%557.58M	-45.00%312.57M	-5.76%2.15B	14.42%2.03B	6.87%1.41B	-0.98%568.33M	-32.84%2.28B
Minority profit	-171.60%-55.49M	-65.87%42.69M	-39.49%89.71M	227.70%64.73M	59,975.46%77.5M	-52.83%125.08M	-11.54%148.24M	-84.28%19.75M	-100.23%-129.43K	-48.76%265.17M
Profit attributable to shareholders	-29.61%165.47M	-79.99%405.14M	-56.72%813.43M	-64.50%492.85M	-58.65%235.07M	0.43%2.02B	17.13%1.88B	16.47%1.39B	9.65%568.46M	-29.98%2.02B
Basic earnings per share	-29.63%0.19	-79.91%0.47	-56.68%0.94	-64.60%0.57	-59.09%0.27	0.43%2.34	16.67%2.17	16.67%1.61	10.00%0.66	-29.82%2.33
Diluted earnings per share	-29.63%0.19	-79.91%0.47	-56.68%0.94	-64.60%0.57	-59.09%0.27	0.43%2.34	16.67%2.17	16.67%1.61	10.00%0.66	-29.61%2.33
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	IAS
Audit Opinions	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion
Auditor	--	Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited	--	--	--	Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited	--	--	--	Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios. The U.S. has sparked a tariff storm, triggering global market volatility. When the market fluctuates violently, more investment opportunities often appear. Compared with choosing individual stocks, investing in ETFs of the broader market can more easily capture opportunities for market reversals. Disclaimer: Among the U.S. stock market index ETFs: EFF, which is in the top 3 in terms of asset size among the fear index ETFs; the top 3 ETFs in terms of asset size among the S&P 500 index ETFs; and the corresponding leveraged ETFs; the top 4 ETFs in terms of asset size among the Nasdaq ETFs; and the top 3 ETFs in terms of asset size among the Dow Jones Index. This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors' financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. FUTU makes no representation or warranty as to its adequacy, completeness, accuracy or timeline for any particular purpose of the above content. Instutional holding and portfolio information provided is based data in 13f filings. The composition provided is updated on a significant delay and may be incomplete. It is not possible to replicate the timing or exact holdings and portfolios.

No. Symbol 5D % Chg

SPDR Dow Jones Industrial Average Trust

DIA